English
Home > Products > 136489-37-7

China 136489-37-7 Factory

No matter new buyer or aged buyer, We believe in prolonged expression and trustworthy relationship for 136489-37-7,CAS NO 136489-37-7,Valacyclovir API,Valacyclovir, We are devoted to provide professional purification technology and solutions for you!
136489-37-7, We pursue the management tenet of "Quality is superior, Service is supreme, Reputation is first", and will sincerely create and share success with all clients. We welcome you to contact us for more information and look forward to working with you.

Related Products

Hot Products

  • 4-Chlorophenoxyacetyl chloride

    4-Chlorophenoxyacetyl chloride

    Product Name:4-Chlorophenoxyacetyl chloride
    Molecular Formula:C8H6Cl2O2
    Molecular Weight:205.04
    CAS Registry Number:4122-68-3
  • Norfloxacin Capsules

    Norfloxacin Capsules

    Product Name:Norfloxacin Capsules
    Dosage:0.1g
    Application:Antibiotic
  • 2-Bromo-5-nitropyridine

    2-Bromo-5-nitropyridine

    Product Name:2-Bromo-5-nitropyridine
    Molecular Formula:C5H3BrN2O2
    Molecular Weight:202.99
    CAS Registry Number:4487-59-6
  • SODIUM 2,6-DIFLUOROBENZOATE

    SODIUM 2,6-DIFLUOROBENZOATE

    Product Name:SODIUM 2,6-DIFLUOROBENZOATE
    Molecular Formula:C7H3F2NaO2
    Molecular Weight:180.0840964
    CAS Registry Number:6185-28-0
  • 5-Amino-2-methoxypyridine

    5-Amino-2-methoxypyridine

    Product Name:5-Amino-2-methoxypyridine
    Molecular Formula:C6H8N2O
    Molecular Weight:124.14
    CAS Registry Number:6628-77-9
  • Cetrorelix acetate

    Cetrorelix acetate

    Product Name:Cetrorelix acetate
    Molecular Formula:C70H92ClN17O14
    Molecular Weight;1431.04
    CAS Registry Number;120287-85-6/130143-01-0
  • Related Blog
  • Reviews

  • Gilteritinib Fumarate

    Sandoo Pharmaceutica is a professional pharmaceutical intermediates manufacturer. We provide good quality Gilteritinib Fumarate Cas: 1254053-43-4. Welcome and we look forward to your inquiry!

  • Pharmaceutical Intermediates Manufacturers - Something You Need to Know About Pharma Intermediates Industry

    Pharmaceutical intermediates are actually chemical raw materials or chemical products that need to be used in the synthesis of drugs. Such chemical products can be produced in ordinary chemical plants without obtaining a pharmaceutical production license. As long as the technical indicators meet certain level requirements, they can be used to participate in the synthesis and production of drugs.

  • CAS 148553-50-8 What is Pregabalin?

    Pregabalin is an anti-epileptic drug, also called an anticonvulsant. It works by slowing down impulses within the brain that cause seizures. Pregabalin also affects chemicals within the brain that send pain signals across the systema nervosum.

  • What is the difference between API and FDF in pharma？

    In the pharmaceutical industry, you might hear the terms “FDF” and “API” frequently used in reference to products. We surely understand this type of jargon, but we certainly can see how the general public would feel overwhelmed looking at those kinds of terminology abbreviations. This article is for explaining the difference between API and FDF. For reference, they mean, respectively, “finished dosage form” and “active pharmaceutical ingredient.”

  • What is an Active Pharmaceutical Ingredient (API in Pharma)?

    Sandoo Pharmaceutical is a professional active pharmaceutical intermediate manufacturer, producing high quality APIs. Sandoo Pharmaceutical provides a wide range of active pharmaceutical intermediates.

  • Everything You Need To Know About Active Pharmaceutical Ingredients (API In Pharma)

    Sandoo, as a professional API manufactruer in China, we produces a wide range of active pharmaceutical ingredients which can be used in the production of medicines in different applications.

Related Search

CAS NO 136489-37-7

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept